REGAFFAIRS AI
Guide · 2026-11-08 · 5 min

Annex III cosmetics regulation ingredient checks explained

Annex III restricts cosmetic ingredients in the EU. Check substance identity, product type, concentration, warnings and amendment dates before use.

Annex III of the EU Cosmetics Regulation lists restricted substances, which cosmetic products may contain only under the entry's conditions. Annex II lists prohibited substances. For an Annex III cosmetics regulation check, read the full entry for the intended use. Article 14 and the annexes set these rules.

A matching ingredient name is only the start. You must match the product category, concentration basis, other conditions and label wording too. This guide concerns products supplied to the EU market.

Which annex should you check?

The EU Cosmetics Regulation separates prohibitions, restrictions and lists for specific functions:

AnnexWhat it coversQuestion to answer
IIProhibited substancesDoes a prohibition cover this substance?
IIIRestricted substancesDoes the intended use meet every applicable condition?
IVAllowed colourantsIs the colourant use listed and compliant?
VAllowed preservativesIs the preservative use listed and compliant?
VIAllowed UV filtersIs the UV-filter use listed and compliant?

For the list of banned cosmetic ingredients in the EU, start with Annex II rather than Annex III. But absence from both annexes does not establish permission. Check the ingredient's function against the positive-list rules in Article 14. Hair colourants have a separate qualification in that article, so Annex IV is not a list that every hair colourant must appear on.

How to read an Annex III entry

Match the legal identity

Start with columns a–e: reference number, chemical name or INN, Common Ingredients Glossary name, CAS number and EC number. Compare these with the actual raw material. Read the chemical scope as well as the identifiers: an entry can cover groups, salts or related substances. A trade name or single CAS match is not enough. See the Annex III column headings and entries.

Check the form too. The annex preamble says Annexes III–VI do not cover nanomaterials unless specifically mentioned. Do not assume an ordinary-form entry covers a nanoform.

Follow the correct product row

Column f gives the product type or body parts. Column g gives the maximum concentration in the ready-for-use preparation. Column h contains other restrictions, while column i gives conditions-of-use and warning wording. Match lettered subrows across all these columns. You cannot take the maximum from one product category and the conditions from another. See the legal entry.

Read beyond the percentage

Check what the percentage measures. Depending on the entry, limits can use an acid, free-base, elemental or retinol-equivalent basis. Read footnotes for combined-use conditions and check any purity, pH, age or exposure restrictions. Use the basis in the applicable entry.

Then check the label. Article 19 requires the relevant precautions in Annexes III–VI, plus applicable professional-use precautions, on the label. It also provides for Annex III ingredient declarations in addition to "parfum" or "aroma". A formula under the concentration ceiling can still need label changes. See Article 19.

Vitamin A as a worked example

Annex III entry 376 covers Retinol, Retinyl Acetate and Retinyl Palmitate. Regulation 2024/996 sets these ready-for-use limits:

  • Body lotion: 0.05% Retinol Equivalent (RE).
  • Other leave-on and rinse-off products: 0.3% RE.

For example, 0.1% RE is below the ceiling for an applicable non-body-lotion leave-on product, but above the body-lotion ceiling. That comparison does not approve the product. The percentages refer to RE, not automatically to the percentage of supplied raw material. Identity, warnings, other conditions and finished-product safety still need checking.

The required warning is "Contains Vitamin A. Consider your daily intake before use". For products that do not meet the conditions, placement on the Union market has been prohibited since 1 November 2025. Making them available is prohibited from 1 May 2027. The May 2026 consolidated text retains these requirements. Do not apply this entry as one uniform limit for all retinoids.

Check amendments and both transition dates

Fragrance allergens show why label thresholds and use limits need separate checks. Regulation 2023/1545 expanded individual declarations. Relevant declarations apply when concentrations exceed 0.001% in leave-on products or 0.01% in rinse-off products. These are declaration thresholds, not universal permitted-use maxima. Some entries have separate restrictions.

Qualifying products that do not meet the new restrictions could be placed on the Union market until 31 July 2026 and made available until 31 July 2028. For specified existing entries, that depends on compliance with the restrictions applicable on 15 August 2023. As of 8 November 2026, the placement transition has expired. Qualifying stock already placed may still fall within the availability transition. An English-relevant corrigendum of 11 November 2025 corrects some names and entries, not those dates. Use the corrected names, and read the entry's footnote rather than assuming every product qualifies.

Under Article 2, placing on the market means the first making available. Making available means supply in a commercial activity. These are not manufacturing and expiry dates.

Later amendments matter too. Regulation 2026/909 replaces entries including Citral and Benzyl Salicylate. It adds product-specific restrictions and keeps the allergen declarations. Its separate transitions do not extend the 2023 fragrance deadlines across the board.

Use the base act's version selector and authentic amending acts to check later changes before a formulation decision. Retain the exact version used. The consolidated text cited here is dated 18 May 2026. Consolidations have no legal effect. Authentic Official Journal acts control.

Finish the ingredient check

CosIng is informative and has no legal value. An INCI name in its inventory is not approval. Use it to locate identities and references, then read the law.

Annex compliance does not replace the finished-product safety assessment. Article 3 requires safety under normal or reasonably foreseeable use. Article 15 separately prohibits relevant harmonised CMR substances, subject to its specified exceptions. Article 17 permits small, unintended traces of prohibited substances only when technically unavoidable under good manufacturing practice and consistent with Article 3. It does not permit intentional addition. Check these legal requirements before closing the assessment.

RegAffairs AI's ingredient-restriction answer explains the annex lookup and how to read a restricted-ingredient entry.

Related guides